Lanreotide Reduces the Volume of Polycystic Liver: A Randomized, Double-Blind, Placebo-Controlled Trial
To access this article, please choose from the options below
To view this article's video abstract, go to the AGA's YouTube Channel.
Conflicts of interest The authors disclose the following: Robert A. de Man: consulting and lecture fees and grant support from Gilead Sciences, consulting fees and grant support from Bristol–Myers Squibb, consulting fees from Novartis, and lecture fees from UCB. Joost P. H. Drenth: grant/research support from Roche. The remaining authors disclose no conflicts.
Funding Supported by Ipsen, Boulogne Billancourt, France, and a ZON-MW VIDI research grant (J.P.H.D.).
PII: S0016-5085(09)01377-8
doi:10.1053/j.gastro.2009.07.052
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.

